BIOMAT Database Logo BIOMAT Database Logo

[Cytology in the diagnosis of chronic hepatopathies]. 1988

G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001707 Biopsy, Needle Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed. Aspiration Biopsy,Puncture Biopsy,Aspiration Biopsies,Biopsies, Aspiration,Biopsies, Needle,Biopsies, Puncture,Biopsy, Aspiration,Biopsy, Puncture,Needle Biopsies,Needle Biopsy,Puncture Biopsies

Related Publications

G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Serum enzymogram in the diagnosis of chronic hepatopathies].
June 1974, Medicina interna,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Role of immunological studies in the diagnosis of chronic hepatopathies].
December 1973, Medicina interna,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Value of liver histology in diagnosis of chronic hepatopathies].
October 1998, Praxis,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[The diagnosis of chronic hepatopathies in primary care: autoimmune chronic active hepatitis type 1].
May 1993, Atencion primaria,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
May 1992, Medicina clinica,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
August 1964, Medicina interna,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[On the diagnosis and therapy of chronic hepatopathies. Experiences with Orgatract].
June 1965, Therapie der Gegenwart,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Dehydroepiandrosterone in chronic hepatopathies].
August 1966, Casopis lekaru ceskych,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Pseudocholinesterase in chronic hepatopathies].
November 1967, Il Policlinico. Sezione pratica,
G Genova, and V Franco, and C Rimi, and S Sarcona, and R Castellucci, and M R Rizzuto
[Alphamercaptopropionylglycine in chronic hepatopathies].
January 1972, Il Policlinico. Sezione medica,
Copied contents to your clipboard!